Related Experiment Video
Updated: May 31, 2026
03:53
Regenerative Peripheral Nerve Interface: Surgical Protocol for a Randomized Controlled Trial in Postamputation Pain
Published on: March 15, 2024
New developments in the treatment algorithm for peripheral neuropathic pain
1School of Medicine and Biomedical Sciences, University at Buffalo, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. oscar.deleon@roswellpark.org
Pain Medicine (Malden, Mass.)
|July 15, 2011
Summary
Managing neuropathic pain is challenging, with limited effectiveness from single-agent analgesics. Current guidelines recommend several drug classes, but knowledge gaps persist, necessitating further research for improved multimodal treatments.
Area of Science:
- Pain Medicine
- Neurology
- Pharmacology
Background:
- Neuropathic pain presents a significant and persistent challenge for patients, often inadequately managed by single-drug therapies.
- Existing treatment recommendations from various international bodies highlight common analgesic classes.
- Despite current guidelines, substantial knowledge gaps impede the development of effective multimodal treatment strategies for neuropathic pain.
Purpose of the Study:
- To review current global treatment recommendations for neuropathic pain.
- To identify common analgesic agents recommended across major guidelines.
- To highlight existing knowledge gaps and the need for further research in neuropathic pain management.
Main Methods:
- Analysis of five sets of international treatment recommendations for neuropathic pain (European, Canadian, Latin American, IASP).
- Identification of analgesic classes consistently included in these guidelines.
- Assessment of current limitations and future directions in neuropathic pain management research.
Main Results:
- Commonly recommended analgesics include topical lidocaine, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, alpha-2-delta ligands, tramadol, and opioid antagonists.
- Significant knowledge deficits hinder the creation of comprehensive treatment algorithms and multimodal approaches.
- Emerging treatments, like high-concentration capsaicin patches, offer new therapeutic possibilities.
Conclusions:
- Current neuropathic pain management relies on a set of established drug classes, but their efficacy is often limited.
- Further research and comparative trial data are crucial for refining clinical management guidelines.
- Novel therapeutic options are expanding the treatment landscape and may influence future clinical practice.
Related Concept Videos
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...